Founded in 2014 in Miami, Florida, HeartIn Inc. is constantly driving innovations forward, aiming to accelerate the development of telemedicine and remote cardiology in particular. After more than 9 years since the initiation of the idea, dozens of various prototypes and continuous development, HeartIn is ready to present its product â the future of remote cardiac assessment, which is available already today. According to WHO, more than 10 000 000 people die every year due to cardiovascular diseases. What is even more shocking, 80% of these deaths could have been prevented. We live in a busy world, and itâs often hard to convince yourself to visit a hospital without actual need. Our goal is to provide people with an easy-to-use tool for medical grade accuracy heart monitoring, which can be performed anywhere. Source
No articles found.
Adaptimmune is a leader in TCR T-cell therapy, focused on developing novel cancer ...
Adaptimmune is a leader in TCR T-cell therapy, ...
At GlycoMimetics, we are committed to helping to make a difference in the lives of...
At GlycoMimetics, we are committed to helping t...
A patient that is diagnosed with cancer today will have a genetic screen on their ...
A patient that is diagnosed with cancer today w...
EpigenCare is connecting consumers with skincare companies through a direct-to-con...
EpigenCare is connecting consumers with skincar...
Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrate...
Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a Sa...
Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-i...
Aerpio Pharmaceuticals is a biopharmaceutical c...
Founded in 1941 in Tokyo, Japan, Hoya is a global med-tech company, and a leading ...
Founded in 1941 in Tokyo, Japan, Hoya is a glob...
Join the National Investor Network and get the latest information with your interests in mind.